ScholarWorks@Hanyang University: Kim, Hee Jin

Detailed Information

Kim, Hee Jin (김희진)

서울 의과대학 (DEPARTMENT OF NEUROLOGY)

Research Area: 신경과학, 치매

Tel 02-2290-8374
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Alzheimer&apos:9||s disease:9||Dementia:8||dementia:7||Alzheimer’s disease:6||Frontotemporal dementia:5||cognition:5||치매:4||Mild cognitive impairment:3||bloodbrain barrier:3||Asia:3||amyotrophic lateral sclerosis:3||brain:2||cognitive impairment:2||neuroprotection:2||Activities of daily living:2||경도인지장애:2||Alzheimer's disease:2||Korea:2||Alzheimer disease:2||melatonin:2||permeability:2||voxelbased morphometry:2||magnetic resonance imaging:2||Inflammation:2||The Long Goodbye:2||resveratrol:2||CSF1R:1||Cameras:1||Caregiver:1||Caregivers:1||Carotid artery stenosis:1||Carotid artery stenting:1||Case marker processing ability:1||Cavernous Nerve Injury:1||Cell therapy:1||Cerebral hyperperfusion syndrome:1||Cerebral palsy:1||Cerebrospinal fluid:1||Chirp:1||Clinical assessment:1||Clinical symptoms:1||Cognition:1||Cognitive Impairment:1||Cognitive intervention:1||Cognitive screening test:1||Computerbased cognitive training:1||Contrastenhanced fluidattenuated:1||Cord blood:1||Culture:1||DHP1401:1||Diabetes mellitus:1||Diagnosis:1||Diffusion tensor image:1||Diffusionweighted image:1||Discrete Fourier transforms:1||Disease incidence:1||Donepezil:1||Doppler radar:1||Earlyonset Alzheimer&apos:1||Erythropoietin:1||Extended kalman filter:1||Foot:1||GHSR1 alpha agonist:1||GRN:1||Genetic algorithm:1||Granulin:1||GuillainBarre′Syndrome:1||Iatrogenic Erectile Dysfunction:1||Induction motor speed control:1||Influenza:1||Iron:1||KAD8:1||Knowledge:1||Language:1||Learning and memory:1||Legged locomotion:1||M139I:1||MAPT:1||MIMO FMCW radar:1||MTHFR C677T polymorphism:1||Magnetic resonance imaging:1||Mass screening:1||Memantine:1||Microglia:1||Mild Cognitive Impairment:1||Mild cognitive disorder:1||Minimental state examination:1||Mononuclear cells:1||Multinational studies:1||Needs:1||Neural network:1||Neuronal plasticity:1||Neuroprotection:1||Neuropsychiatric Inventory:1||Neuropsychiatric Inventory Questionnaire:1||Neuropsychiatric symptoms:1||Neuropsychological inventory:1||Nextgeneration sequencing:1||Nonpharmaceutical treatment:1||PET/CT:1||PRNP:1||Paradoxical tuberculoma:1||Penile Rehabilitation:1||Personalized Medicine:1||Philip Marlowe:1||Phosphodiesterase III inhibitor:1||Phosphodiesterase Inhibitors:1||Presenilin 1:1||Public Education:1||Pulvinar nucleus:1||RBD screening questionnaire:1||REM sleep disorder:1||Radar measurements:1||Radical Prostatectomy:1||Raymond Chandler:1||Risk factors:1||Robert Altman:1||SOD1:1||Scale:1||Sleep:1||Sleep Quality:1||Status epilepticus:1||Syntactic complexity:1||T:1||T2(star) relaxometry:1||TDP43 inclusion:1||THK5117:1||Tau:1||Telomere:1||Thalamus:1||Transneuronal tractopathy:1||Tuberculous meningitis:1||Vaccination:1||Validity:1||Vascular dementia:1||Voxel based morphometry:1||Wallerian degeneration:1||acetylcholinesterase inhibitor:1||acid sphingomyelinase:1||aging:1||amyloid:1||atrophy:1||atrophy.:1||biomarkers:1||blood pressure:1||brain volumetry:1||brief informantbased measure:1||c.499C>:1||caregiver education:1||caveolae:1||cellular changes:1||cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy:1||cerebrovascular disorder:1||cholinergic pathway:1||clinical dementia rating:1||cognitive function:1||communitybased cognitive intervention program:1||correlation studies:1||corticocortical interaction:1||deep learning:1||diffusionweighted image:1||donepezil:1||donepezil transdermal patch:1||dynamic PET:1||efficacy:1||electroencephalography:1||emotion:1||emotion perception:1||enlarged perivascular spaces:1||facial expression:1||frontotemporal dementia:1||frontotemporal lobar degeneration:1||gait analysis:1||gait asymmetry:1||glycogen synthase kinase 3 beta:1||gray matter:1||hardboiled:1||heme oxygenase1:1||hippocampus:1||homocysteine:1||hypertension:1||individual leg perception:1||inversion recovery imaging:1||lacune:1||mediation:1||memory improvement:1||metabolic syndrome X:1||methylenetetrahydrofolate reductase:1||microscopic changes:1||mild cognitive impairment:1||mild to moderate AD:1||neonoir.:1||neural function:1||neurocognitive disorders:1||neurodegeneration:1||neurology:1||nextgeneration sequencing:1||noir:1||normal aging:1||nucleus basalis of Meynert:1||p.P167S:1||perfusion:1||phase synchronization:1||population:1||putamen:1||quality of life:1||randomized placebocontrolled clinical trial:1||reactive oxygen species:1||reliability:1||repetitive transcranial magnetic stimulation:1||research methods:1||retrospective studies:1||risk factors:1||s Disease:1||safety:1||screening:1||sexspecific effect:1||small compound:1||structural changes:1||subcortical ischemic vascular dementia:1||subcortical structure:1||subjective cognitive decline:1||temporal cortex:1||transient global amnesia:1||treatment compliance.:1||ubiquitination:1||uric acid:1||urinary symptoms:1||validity:1||very mild dementia:1||voxel based morphometry:1||『기나긴 이별』:1||과민성방광증상:1||긴 이별>:1||네오 누아르.:1||뇌영상:1||뇌척수액:1||레이먼드 챈들러:1||로버트 알트만:1||바이오마커:1||비약물적 치료:1||신경가소성:1||아포지단백 유전자:1||알츠하이머병:1||위험요인:1||인지중재:1||임상증상:1||진단방법:1||타우:1||필름 누아르:1||필립 말로우:1||:1||하드보일드 추리소설:1||<:1||AARS2:1||AD8:1||ALS:1||AMPactivated protein kinase:1||APOE genotype:1||APOE4:1||ASM direct inhibitor:1||Aggregation:1||Alzheimer Disease:1||Alzheimer’s Disease:1||Ambientassisted living:1||Amyloid Plaques:1||Amyotrophic lateral sclerosis:1||Anticipatory Dementia:1||Anxiety:1||ApoE genotype:1||Attention:1||Awareness:1||Behavioral and psychological symptoms:1||Biomarker:1||Biomarkers:1||Brain atrophy:1||Burden:1||CADASIL:1||CSF clearance:1||

RSS_1.0 RSS_2.0 ATOM_1.0

222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE